Field-assisted paper spray mass spectrometry for therapeutic drug monitoring: 1. the case of imatinib in plasma.

about

Field-assisted paper spray mass spectrometry for therapeutic drug monitoring: 1. the case of imatinib in plasma.

Item

http://www.wikidata.org/entity/Q48174042

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Field-assisted paper spray mas ...... he case of imatinib in plasma.

@en

Field-assisted paper spray mas ...... he case of imatinib in plasma.

@nl

type

Item

label

Field-assisted paper spray mas ...... he case of imatinib in plasma.

@en

Field-assisted paper spray mas ...... he case of imatinib in plasma.

@nl

prefLabel

Field-assisted paper spray mas ...... he case of imatinib in plasma.

@en

Field-assisted paper spray mas ...... he case of imatinib in plasma.

@nl

P1476

Field-assisted paper spray mas ...... he case of imatinib in plasma.

@en

P2093

A Buonadonna

http://www.w3.org/2001/XMLSchema#string

M Dall'Armi

http://www.w3.org/2001/XMLSchema#string

P Traldi

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical methods for assessing agreement between two methods of clinical measurement

Fluorescence studies of anti-cancer drugs--analytical and biomedical applications.

Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia.

Quantitative high-throughput analysis of drugs in biological matrices by mass spectrometry.

Paper spray ionization devices for direct, biomedical analysis using mass spectrometry.

Field-assisted paper spray mass spectrometry for the quantitative evaluation of imatinib levels in plasma.

Current role of LC-MS in therapeutic drug monitoring.

High rates of durable response are achieved with imatinib after treatment with interferon alpha plus cytarabine: results from the International Randomized Study of Interferon and STI571 (IRIS) trial.

Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.

Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusion.

P304

283-289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMS.3927

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28251731

http://www.w3.org/2001/XMLSchema#string